Skip to main content
Log in

Societal costs of chemotherapy for early breast cancer substantial in UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Parsekar K, et al. Societal costs of chemotherapy in the UK: an incidence-based cost-of-illness model for early breast cancer. BMJ Open : 11 Jan 2021. Available from: URL: http://dx.doi.org/10.1136/bmjopen-2020-039412

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Societal costs of chemotherapy for early breast cancer substantial in UK. PharmacoEcon Outcomes News 870, 28 (2021). https://doi.org/10.1007/s40274-021-7431-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7431-7

Navigation